Patent details
EP2326731 Title: BIOMARKERS FOR ANTI-TNF TREATMENT IN ULCERATIVE COLITIS AND RELATED DISORDERS
Basic Information
- Publication number:
- EP2326731
- PCT Application Number:
- PCT/US/2009/054287
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP098209570
- PCT Publication Number:
- WO/2010/044952
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- BIOMARKERS FOR ANTI-TNF TREATMENT IN ULCERATIVE COLITIS AND RELATED DISORDERS
- French Title of Invention:
- BIOMARQUEURS POUR LE TRAITEMENT ANTI-TNF DANS LA RECTOCOLITE HÉMORRAGIQUE ET DE TROUBLES ASSOCIÉS
- German Title of Invention:
- BIOMARKER ZUR ANTI-TNF-BEHANDLUNG BEI COLITIS ULCEROSA UND DAMIT ZUSAMMENHÄNGENDEN ERKRANKUNGEN
- SPC Number:
Dates
- Filing date:
- 19/08/2009
- Grant date:
- 13/11/2013
- EP Publication Date:
- 13/11/2013
- PCT Publication Date:
- 22/04/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/06/2011
- EP B1 Publication Date:
- 13/11/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 19/08/2014
- Expiration date:
- 19/08/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/08/2009
- Name:
- Janssen Biotech, Inc.
- Address:
- 800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)
Inventor
1
- Name:
- LI Katherine
- Address:
- United States (US)
2
- Name:
- BARIBAUD Frederic
- Address:
- United States (US)
Priority
- Priority Number:
- 91641 P
- Priority Date:
- 25/08/2008
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C12Q 1/68;
| Filing date | Document type | Number of pages |
|---|